A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules
- 11 August 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Robotics
- Vol. 6 (57)
Abstract
Intraperitoneal insulin release is achieved using an implantable reservoir that is refilled with magnetic pills.Keywords
This publication has 33 references indexed in Scilit:
- The hybrid OmniClimber robot: Wheel based climbing, arm based plane transition, and switchable magnet adhesionMechatronics, 2016
- Design and Development of a Mechatronic System for Noninvasive Refilling of Implantable Artificial PancreasIEEE/ASME Transactions on Mechatronics, 2014
- Wireless Capsule Endoscope for Targeted Drug Delivery: Mechanics and Design ConsiderationsIEEE Transactions on Biomedical Engineering, 2013
- Ports and complications for intraperitoneal chemotherapy deliveryBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Reducing Excessive Toxicity in Ovarian Cancer Treatment: A Personalized ApproachFuture Oncology, 2011
- Intraperitoneal Therapy for Peritoneal CancerFuture Oncology, 2010
- A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusionDiabetes, Obesity and Metabolism, 2009
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Industrial applications of permanent magnetismPhysica Scripta, 1996
- Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter studyDiabetes Care, 1995